Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher G Sobey

Showing results (11-20 of 217) with videos related to

Pageof 22
Sort By:
Circulation Research|September 28, 2013
CEACAM1: an adhesion molecule that limits blood-brain barrier damage by neutrophils after strokeChristopher G Sobey, Grant R Drummond
Clinical and Experimental Pharmacology & Physiology|December 18, 2003
Cerebral vascular effects of reactive oxygen species: recent evidence for a role of NADPH-oxidaseTamara M Paravicini, Christopher G Sobey
American Journal of Physiology. Cell Physiology|March 15, 2006
Radicals spark interest in cerebral vasodilator mechanisms. Focus on "TNF-alpha dilates cerebral arteries via NAD(P)H oxidase-dependent Ca2+ spark activation"Christopher G Sobey, Alyson A Miller
British Journal of Pharmacology|May 26, 2019
Immunity and hypertension: New targets to lighten the pressureAntony Vinh, Grant R Drummond, Christopher G Sobey
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|May 8, 2004
Chronic mevastatin modulates receptor-dependent vascular contraction in eNOS-deficient miceKlaudia Budzyn, Philip D Marley, Christopher G Sobey
Trends in Pharmacological Sciences|December 27, 2005
Targeting Rho and Rho-kinase in the treatment of cardiovascular diseaseKlaudia Budzyn, Philip D Marley, Christopher G Sobey
Clinical Science (London, England : 1979)|April 8, 2010
Vascular dysfunction in cerebrovascular disease: mechanisms and therapeutic interventionAlyson A Miller, Klaudia Budzyn, Christopher G Sobey
Journal of Hypertension|June 25, 2010
Reduced cerebrovascular remodeling and functional impairment in spontaneously hypertensive rats following combined treatment with suboptimal doses of telmisartan and ramipril: is less really more?Klaudia Budzyn, Christopher G Sobey, Grant R Drummond
The Journal of Pharmacology and Experimental Therapeutics|March 4, 2005
Opposing roles of endothelial and smooth muscle phosphatidylinositol 3-kinase in vasoconstriction: effects of rho-kinase and hypertensionKlaudia Budzyn, Philip D Marley, Christopher G Sobey
Current Medicinal Chemistry|November 30, 2007
Isoflavones, equol and cardiovascular disease: pharmacological and therapeutic insightsKatherine A Jackman, Owen L Woodman, Christopher G Sobey
Pageof 22

Showing results (11-20 of 217) with videos related to

Sort By:
Pageof 22
Circulation Research|September 28, 2013
CEACAM1: an adhesion molecule that limits blood-brain barrier damage by neutrophils after strokeChristopher G Sobey, Grant R Drummond
Clinical and Experimental Pharmacology & Physiology|December 18, 2003
Cerebral vascular effects of reactive oxygen species: recent evidence for a role of NADPH-oxidaseTamara M Paravicini, Christopher G Sobey
American Journal of Physiology. Cell Physiology|March 15, 2006
Radicals spark interest in cerebral vasodilator mechanisms. Focus on "TNF-alpha dilates cerebral arteries via NAD(P)H oxidase-dependent Ca2+ spark activation"Christopher G Sobey, Alyson A Miller
British Journal of Pharmacology|May 26, 2019
Immunity and hypertension: New targets to lighten the pressureAntony Vinh, Grant R Drummond, Christopher G Sobey
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|May 8, 2004
Chronic mevastatin modulates receptor-dependent vascular contraction in eNOS-deficient miceKlaudia Budzyn, Philip D Marley, Christopher G Sobey
Trends in Pharmacological Sciences|December 27, 2005
Targeting Rho and Rho-kinase in the treatment of cardiovascular diseaseKlaudia Budzyn, Philip D Marley, Christopher G Sobey
Clinical Science (London, England : 1979)|April 8, 2010
Vascular dysfunction in cerebrovascular disease: mechanisms and therapeutic interventionAlyson A Miller, Klaudia Budzyn, Christopher G Sobey
Journal of Hypertension|June 25, 2010
Reduced cerebrovascular remodeling and functional impairment in spontaneously hypertensive rats following combined treatment with suboptimal doses of telmisartan and ramipril: is less really more?Klaudia Budzyn, Christopher G Sobey, Grant R Drummond
The Journal of Pharmacology and Experimental Therapeutics|March 4, 2005
Opposing roles of endothelial and smooth muscle phosphatidylinositol 3-kinase in vasoconstriction: effects of rho-kinase and hypertensionKlaudia Budzyn, Philip D Marley, Christopher G Sobey
Current Medicinal Chemistry|November 30, 2007
Isoflavones, equol and cardiovascular disease: pharmacological and therapeutic insightsKatherine A Jackman, Owen L Woodman, Christopher G Sobey
Pageof 22